A Study for Identification of Predictive Immune Biomarker for Atezolizumab Therapy in NSCLC Patients

Clinical trial NCT04312308 · COMPLETED

Trial details

NCT number: NCT04312308
Sponsor: Yonsei University
Status: COMPLETED
Study type: OBSERVATIONAL

Non Small Cell Lung Cancer

Start date: 2020-04-08
Primary completion: 2025-01-26
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.